Eupaglehnin C is primarily studied for its potential biological activities, particularly in the field of natural product-based drug discovery. It has shown promising anti-inflammatory and antioxidant effects in preliminary in vitro studies, making it a candidate for further research in treating oxidative stress-related conditions. Additionally, it exhibits moderate cytotoxic activity against certain cancer cell lines, suggesting possible applications in oncology for developing new chemotherapeutic agents. Due to its natural origin and structural complexity, it also serves as a lead compound for synthesizing derivatives to enhance potency and selectivity. Research remains in early stages, focusing on isolation optimization and pharmacological profiling.